Artesunate for the treatment of severe falciparum malaria.

@article{Rosenthal2008ArtesunateFT,
  title={Artesunate for the treatment of severe falciparum malaria.},
  author={Philip J. Rosenthal},
  journal={The New England journal of medicine},
  year={2008},
  volume={358 17},
  pages={
          1829-36
        }
}
  • P. Rosenthal
  • Published 24 April 2008
  • Medicine
  • The New England journal of medicine
A 35-year-old man presents with a febrile illness after travel in West Africa, and severe malaria is diagnosed. Treatment with artesunate is recommended. Artesunate is a member of a class of antimalarial agents called artemisinins, and it is at least as effective against severe malaria as quinine, with fewer side effects. The drug is available in the United States only by special request from the Centers for Disease Control and Prevention. 
Artemisinins in malaria treatment in the UK
  • Medicine
  • Drug and Therapeutics Bulletin
  • 2010
TLDR
The role of artemisinins as treatment for malaria in the UK is considered, and the parenteral artemisInin for severe malaria, artesunate, is not licensed in developed countries. Expand
Combined intravenous treatment with artesunate and quinine for severe malaria in Italy.
TLDR
This report reports a series of eight imported severe falciparum malaria cases treated with IVA combined with intravenous quinine (IVQ), which was found to be efficacious, safe, and well-tolerated. Expand
Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
TLDR
In order to ensure the most achievable and reliable adherence and compliance of children in the treatment of malaria, a dispersible formulation of AL is now attainable. Expand
Currently Observed Trend in the Resistance of Malaria to Artemisinin Based Combination Therapy in Nigeria – A Report of 5 Cases
TLDR
The need for a re-evaluation of the malaria treatment protocol is emphasized and more light is thrown on the increasing resistance of Plasmodium falciparum to the commonly used Artemisinin – based combination therapy agents in Nigeria. Expand
Treatment of Severe Plasmodium falciparum Malaria With Artesunate: Report of the First Case in the Western United States
TLDR
The first case of severe P. falciparum malaria in the western United States successfully treated with artesunate is reported, and it is reported that the patient's initial level of parasitemia was 30% to 40%. Expand
A Case of Plasmodium falciparum Malaria Treated with Artesunate in a 55-Year-Old Woman on Return to Florida from a Visit to Ghana
TLDR
Given that artesunate is more effective, easier to dose, and more tolerable than quinidine, it is now the treatment of choice for severe malaria in the United States. Expand
Severe Plasmodium falciparum Malaria Treated With Investigational Artesunate in the United States
TLDR
The case of a 40-year-old Nigerian male with severe Plasmodium falciparum malaria successfully treated with investigational intravenous (IV) artesunate procured from the CDC is described. Expand
Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10‐year single‐center experience with a standardized treatment protocol
TLDR
It is confirmed that exchange transfusion was introduced as a standard adjunct therapy for patients with severe malaria and no case fatality has been encountered since it was introduced. Expand
Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria
This review summarizes progress in treating severe and complicated malaria, which are global problems, claiming at least one million lives annually, and have been accompanied by advances in ourExpand
Severe Malaria and Artesunate Treatment, Norway
TLDR
All patients treated with IV artesunate for severe falciparum malaria were Norwegian tourists or businessmen; 4 patients were visiting friends and relatives and had lived in Norway for 2, 15, 20, and 40 years, respectively; none of the patients had used antimalarial chemoprophylaxis; and the pregnant patient delivered a healthy child at term. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
QUINIDINE IN FALCIPARUM MALARIA
TLDR
Quinidine is an effective antimalarial drug for Plasmodium falciparum infections and may be more potent than quinine, and in-vitro cultures showed that the minimum inhibitory concentration was consistently lower for quinidine than forQuinine. Expand
Availability of intravenous quinidine for falciparum malaria.
To the Editor: Intravenous quinidine, the treatment of choice for patients with life-threatening falciparum malaria, is no longer available at many hospitals. A four-year-old boy, born in the UnitedExpand
Artemisinins
TLDR
Comparative trials of artesunate and quinine for severe malaria are in progress to see if the persistently high mortality of this condition can be reduced. Expand
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial
TLDR
Artesunate should become the treatment of choice for severe falciparum malaria in adults because it is more rapidly acting than intravenous quinine in terms of parasite clearance and is simpler to administer. Expand
A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria.
TLDR
Artemether is a satisfactory alternative to quinine for the treatment of severe malaria in adults in Vietnam and is associated with a higher risk of hypoglycemia, but there were no other serious side effects in either group. Expand
Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum.
  • R. McGready, T. Cho, +5 authors F. Nosten
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2001
TLDR
Artesunate or artemether was used to treat 539 episodes of acute P. falciparum malaria in 461 pregnant women, including 44 first-trimester episodes and the artemisinins were well tolerated with no evidence of adverse effects. Expand
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
TLDR
Oral artesunate and artemether alone were very well tolerated and there was no difference in the incidence of possible adverse effects between the two drugs, and no evidence that either derivative caused allergic reactions, neurologic or psychiatric reactions, or cardiovascular or dermatologic toxicity. Expand
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison
TLDR
Both dihydroartemisinin-piperaquine and artemether-lumefantrine were safe and effective for the treatment of multidrug-resistant uncomplicated malaria, however, diHydroart Artemisin in-pipersaquine provided greater post-treatment prophylaxis than did artem ether- lumefanrine, reducing P falciparum reinfections and P vivax recurrences. Expand
The management of patients with severe malaria.
  • N. Day, A. Dondorp
  • Medicine
  • The American journal of tropical medicine and hygiene
  • 2007
TLDR
The antimalarial treatment of severe disease is being transformed by the development and deployment of the water-soluble artemisinin derivative artesunate, and research is underway into whether it should replace quinine as the treatment of choice in African children. Expand
Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand.
TLDR
Quinine remains an effective treatment for severe multi-drug resistant falciparum malaria in this area, but there is now evidence of a decline in the immediate therapeutic response, and its efficacy will need close monitoring as resistance increases further. Expand
...
1
2
3
4
5
...